• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

EB 病毒(EBV)如何在伯基特淋巴瘤的发病机制中补充 Myc 的激活?

How does Epstein-Barr virus (EBV) complement the activation of Myc in the pathogenesis of Burkitt's lymphoma?

机构信息

Department of Virology, Faculty of Medicine, Imperial College London, Norfolk Place, London W2 1PG, UK.

出版信息

Semin Cancer Biol. 2009 Dec;19(6):366-76. doi: 10.1016/j.semcancer.2009.07.007. Epub 2009 Jul 25.

DOI:10.1016/j.semcancer.2009.07.007
PMID:19635566
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3770905/
Abstract

A defining characteristic of the aggressive B cell tumour Burkitt's lymphoma (BL) is a reciprocal chromosomal translocation that activates the Myc oncogene by juxtaposing it to one of the immunoglobulin gene loci. The consequences of activating Myc include cell growth and proliferation that can lead to lymphomagenesis; however, as part of a fail-safe mechanism that has evolved in metazoans to reduce the likelihood of neoplastic disease, activated oncogenes such as Myc may also induce cell death by apoptosis and/or an irreversible block to proliferation called senescence. For lymphoma to develop it is necessary that these latter processes are repressed. More than 95% of a subset of BL - known as endemic (e)BL because they are largely restricted to regions of equatorial Africa and similar geographical regions - carry latent Epstein-Barr virus (EBV) in the form of nuclear extra-chromosomal episomes. Although EBV is not generally regarded as a driving force of BL cell proliferation, it plays an important role in the pathogenesis of eBL. Latency-associated EBV gene products can inhibit a variety of pathways that lead to apoptosis and senescence; therefore EBV probably counteracts the proliferation-restricting activities of deregulated Myc and so facilitates the development of BL.

摘要

侵袭性 B 细胞肿瘤伯基特淋巴瘤(BL)的一个显著特征是一种相互易位,通过将其与免疫球蛋白基因座之一并列,激活 Myc 癌基因。激活 Myc 的后果包括细胞生长和增殖,从而导致淋巴瘤发生;然而,作为后生动物中为降低肿瘤疾病发生可能性而进化出的故障安全机制的一部分,像 Myc 这样的激活癌基因也可能通过细胞凋亡和/或称为衰老的不可逆转增殖阻滞来诱导细胞死亡。为了发展成淋巴瘤,这些后一种过程必须受到抑制。BL 的一个子集 - 称为地方性(e)BL,因为它们主要局限于赤道非洲和类似地理区域 - 超过 95%携带潜伏性 Epstein-Barr 病毒(EBV),形式为核外染色体外体。尽管 EBV 通常不被认为是 BL 细胞增殖的驱动力,但它在 eBL 的发病机制中起着重要作用。潜伏相关 EBV 基因产物可以抑制多种导致凋亡和衰老的途径;因此,EBV 可能会抵消失调 Myc 的增殖抑制活性,从而促进 BL 的发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a96/3770905/c791e78c4076/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a96/3770905/b3eb8c640846/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a96/3770905/c791e78c4076/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a96/3770905/b3eb8c640846/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a96/3770905/c791e78c4076/gr2.jpg

相似文献

1
How does Epstein-Barr virus (EBV) complement the activation of Myc in the pathogenesis of Burkitt's lymphoma?EB 病毒(EBV)如何在伯基特淋巴瘤的发病机制中补充 Myc 的激活?
Semin Cancer Biol. 2009 Dec;19(6):366-76. doi: 10.1016/j.semcancer.2009.07.007. Epub 2009 Jul 25.
2
Epstein-Barr virus and its role in the pathogenesis of Burkitt's lymphoma: an unresolved issue.EB 病毒及其在伯基特淋巴瘤发病机制中的作用:一个未解决的问题。
Semin Cancer Biol. 2009 Dec;19(6):351-65. doi: 10.1016/j.semcancer.2009.07.002. Epub 2009 Jul 18.
3
Latent Epstein-Barr virus infection collaborates with Myc over-expression in normal human B cells to induce Burkitt-like Lymphomas in mice.潜伏的爱泼斯坦-巴尔病毒感染与正常人B细胞中Myc的过表达协同作用,在小鼠中诱导伯基特样淋巴瘤。
PLoS Pathog. 2024 Apr 15;20(4):e1012132. doi: 10.1371/journal.ppat.1012132. eCollection 2024 Apr.
4
Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells.爱泼斯坦-巴尔病毒潜伏的三种受限形式可对抗表达c-myc的伯基特淋巴瘤细胞中的细胞凋亡。
Proc Natl Acad Sci U S A. 2006 Oct 3;103(40):14935-40. doi: 10.1073/pnas.0509988103. Epub 2006 Sep 25.
5
The LCR of EBV makes Burkitt's lymphoma endemic.EB病毒的潜伏膜蛋白使伯基特淋巴瘤呈地方性流行。
Trends Microbiol. 2004 Nov;12(11):495-9. doi: 10.1016/j.tim.2004.09.006.
6
Epstein-Barr virus in Burkitt's lymphoma: a role for latent membrane protein 2A.EB 病毒在伯基特淋巴瘤中的作用:潜伏膜蛋白 2A 的作用。
Cell Cycle. 2010 Mar 1;9(5):901-8. doi: 10.4161/cc.9.5.10840. Epub 2010 Mar 3.
7
Epstein-Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2.爱泼斯坦-巴尔病毒相关的伯基特淋巴瘤发生过程中会选择下调核抗原EBNA2。
Nat Med. 2002 Oct;8(10):1098-104. doi: 10.1038/nm758. Epub 2002 Sep 3.
8
Epstein-Barr virus and Burkitt's lymphoma.爱泼斯坦-巴尔病毒与伯基特淋巴瘤
Semin Cancer Biol. 1992 Oct;3(5):285-95.
9
Latent membrane proteins from EBV differentially target cellular pathways to accelerate MYC-induced lymphomagenesis.EBV 的潜伏膜蛋白通过靶向细胞通路来加速 MYC 诱导的淋巴瘤发生。
Blood Adv. 2022 Jul 26;6(14):4283-4296. doi: 10.1182/bloodadvances.2022007695.
10
Rapamycin reverses splenomegaly and inhibits tumor development in a transgenic model of Epstein-Barr virus-related Burkitt's lymphoma.雷帕霉素逆转了 Epstein-Barr 病毒相关伯基特淋巴瘤转基因模型的脾肿大并抑制肿瘤发展。
Mol Cancer Ther. 2011 Apr;10(4):679-86. doi: 10.1158/1535-7163.MCT-10-0833. Epub 2011 Jan 31.

引用本文的文献

1
The Functional Interaction Between Epstein-Barr Virus and MYC in the Pathogenesis of Burkitt Lymphoma.爱泼斯坦-巴尔病毒与MYC在伯基特淋巴瘤发病机制中的功能相互作用
Cancers (Basel). 2024 Dec 18;16(24):4212. doi: 10.3390/cancers16244212.
2
An Unexpected Lymphoma: A Rare Case of Primary Gastric Burkitt's Lymphoma.意外的淋巴瘤:原发性胃 Burkitt 淋巴瘤罕见病例。
J Investig Med High Impact Case Rep. 2024 Jan-Dec;12:23247096241253341. doi: 10.1177/23247096241253341.
3
MYC directly transactivates CR2/CD21, the receptor of the Epstein-Barr virus, enhancing the viral infection of Burkitt lymphoma cells.

本文引用的文献

1
Differential gene expression patterns of EBV infected EBNA-3A positive and negative human B lymphocytes.EBV感染的EBNA - 3A阳性和阴性人B淋巴细胞的差异基因表达模式。
PLoS Pathog. 2009 Jul;5(7):e1000506. doi: 10.1371/journal.ppat.1000506. Epub 2009 Jul 3.
2
Epstein-barr virus latency in B cells leads to epigenetic repression and CpG methylation of the tumour suppressor gene Bim.爱泼斯坦-巴尔病毒在B细胞中的潜伏导致肿瘤抑制基因Bim的表观遗传抑制和CpG甲基化。
PLoS Pathog. 2009 Jun;5(6):e1000492. doi: 10.1371/journal.ppat.1000492. Epub 2009 Jun 26.
3
c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism.
MYC 可直接激活 EBV 的受体 CR2/CD21,增强伯基特淋巴瘤细胞的病毒感染。
Oncogene. 2023 Nov;42(45):3358-3370. doi: 10.1038/s41388-023-02846-9. Epub 2023 Sep 29.
4
EBV Association with Lymphomas and Carcinomas in the Oral Compartment.口腔部位的淋巴瘤和癌与 EBV 的相关性。
Viruses. 2022 Dec 1;14(12):2700. doi: 10.3390/v14122700.
5
EBV-associated diseases: Current therapeutics and emerging technologies.EBV 相关疾病:当前的治疗方法和新兴技术。
Front Immunol. 2022 Oct 27;13:1059133. doi: 10.3389/fimmu.2022.1059133. eCollection 2022.
6
Cryo-EM Structure and Functional Studies of EBNA1 Binding to the Family of Repeats and Dyad Symmetry Elements of Epstein-Barr Virus .Cryo-EM 结构与 EBNA1 与 Epstein-Barr 病毒家族重复序列和二联体对称元件结合的功能研究
J Virol. 2022 Sep 14;96(17):e0094922. doi: 10.1128/jvi.00949-22. Epub 2022 Aug 29.
7
The Association of Epstein-Barr Virus With Cancer.爱泼斯坦-巴尔病毒与癌症的关联
Cureus. 2022 Jun 25;14(6):e26314. doi: 10.7759/cureus.26314. eCollection 2022 Jun.
8
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.《世界卫生组织造血与淋巴组织肿瘤分类》第五版:淋巴肿瘤。
Leukemia. 2022 Jul;36(7):1720-1748. doi: 10.1038/s41375-022-01620-2. Epub 2022 Jun 22.
9
Reframing Burkitt lymphoma: virology not epidemiology defines clinical variants.重新认识伯基特淋巴瘤:定义临床变异型的是病毒学而非流行病学。
Ann Lymphoma. 2021 Sep;5. doi: 10.21037/aol-21-18. Epub 2021 Sep 30.
10
EBV-Driven Lymphoproliferative Disorders and Lymphomas of the Gastrointestinal Tract: A Spectrum of Entities with a Common Denominator (Part 3).EB病毒驱动的淋巴组织增生性疾病及胃肠道淋巴瘤:一系列具有共同特征的实体(第3部分)
Cancers (Basel). 2021 Nov 30;13(23):6021. doi: 10.3390/cancers13236021.
c-Myc对miR-23a/b的抑制作用增强了线粒体谷氨酰胺酶的表达及谷氨酰胺代谢。
Nature. 2009 Apr 9;458(7239):762-5. doi: 10.1038/nature07823. Epub 2009 Feb 15.
4
Repressing the repressor: a new mode of MYC action in lymphomagenesis.抑制阻遏物:MYC 在淋巴瘤发生中的一种新作用模式。
Cell Cycle. 2009 Feb 15;8(4):556-9. doi: 10.4161/cc.8.4.7599. Epub 2009 Feb 10.
5
The intersection of Epstein-Barr virus with the germinal center.爱泼斯坦-巴尔病毒与生发中心的交集
J Virol. 2009 Apr;83(8):3968-76. doi: 10.1128/JVI.02609-08. Epub 2009 Feb 4.
6
Epstein-Barr virus LMP2A accelerates MYC-induced lymphomagenesis.爱泼斯坦-巴尔病毒LMP2A加速MYC诱导的淋巴瘤发生。
Oncogene. 2009 Mar 19;28(11):1471-6. doi: 10.1038/onc.2008.492. Epub 2009 Feb 2.
7
The Epstein-Barr virus nuclear antigen-1 promotes genomic instability via induction of reactive oxygen species.爱泼斯坦-巴尔病毒核抗原1通过诱导活性氧促进基因组不稳定。
Proc Natl Acad Sci U S A. 2009 Feb 17;106(7):2313-8. doi: 10.1073/pnas.0810619106. Epub 2009 Jan 12.
8
AID is required for the chromosomal breaks in c-myc that lead to c-myc/IgH translocations.AID是c-myc基因发生染色体断裂从而导致c-myc/IgH易位所必需的。
Cell. 2008 Dec 12;135(6):1028-38. doi: 10.1016/j.cell.2008.09.062.
9
Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency.核糖体蛋白单倍剂量不足对Myc致癌活性的抑制作用。
Nature. 2008 Dec 18;456(7224):971-5. doi: 10.1038/nature07449. Epub 2008 Nov 16.
10
The curious case of the tumour virus: 50 years of Burkitt's lymphoma.肿瘤病毒的奇闻:伯基特淋巴瘤50年
Nat Rev Microbiol. 2008 Dec;6(12):913-24. doi: 10.1038/nrmicro2015.